26.09.2016 • NewsElaine BurridgeMerckPEG

Merck to Market JenKem’s PEG products

(c) Merck KGaA
(c) Merck KGaA

The life science arm of Germany’s Merck KGaA has signed an agreement to distribute polyethylene glycol (PEG) products from China’s JenKem Technology. Under the deal’s terms, Merck will market the Chinese’s company’s PEG portfolio to its existing customer base, giving small volume users access through its global distribution network.

Mark Frishberg, vice president of business development at JenKem Technology, said the deal will allow it to leverage Merck’s substantial relationships and infrastructure within the biomedical and related industries.

Headquartered in Beijing, JenKem Technology develops and manufactures PEG products and derivatives, as well as related custom synthesis and PEGylation services. It also has scale-up and commercial manufacturing facilities in Tianjin. JenKem said it will continue to sell PEG products and PEGylation services for small-scale research where customers choose to work directly with the company, as well as for bulk and commercial-scale non-GMP and GMP-grade products.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.